DK0788356T3 - Fremgangsmåde og præparater til hæmning af proteinkinaser - Google Patents

Fremgangsmåde og præparater til hæmning af proteinkinaser

Info

Publication number
DK0788356T3
DK0788356T3 DK95941340T DK95941340T DK0788356T3 DK 0788356 T3 DK0788356 T3 DK 0788356T3 DK 95941340 T DK95941340 T DK 95941340T DK 95941340 T DK95941340 T DK 95941340T DK 0788356 T3 DK0788356 T3 DK 0788356T3
Authority
DK
Denmark
Prior art keywords
preparations
inhibition
methods
independently represents
protein kinases
Prior art date
Application number
DK95941340T
Other languages
Danish (da)
English (en)
Inventor
Neill A Giese
Nathalie Lokker
Original Assignee
Cor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc filed Critical Cor Therapeutics Inc
Application granted granted Critical
Publication of DK0788356T3 publication Critical patent/DK0788356T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
DK95941340T 1994-10-28 1995-10-26 Fremgangsmåde og præparater til hæmning af proteinkinaser DK0788356T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/332,597 US5795910A (en) 1994-10-28 1994-10-28 Method and compositions for inhibiting protein kinases
PCT/US1995/013882 WO1996013259A2 (en) 1994-10-28 1995-10-26 Method and compositions for inhibiting protein kinases

Publications (1)

Publication Number Publication Date
DK0788356T3 true DK0788356T3 (da) 2002-03-18

Family

ID=23298937

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95941340T DK0788356T3 (da) 1994-10-28 1995-10-26 Fremgangsmåde og præparater til hæmning af proteinkinaser

Country Status (14)

Country Link
US (3) US5795910A (zh)
EP (1) EP0788356B9 (zh)
JP (1) JPH10508024A (zh)
KR (1) KR970706812A (zh)
CN (1) CN1165481A (zh)
AT (1) ATE210439T1 (zh)
AU (1) AU706621B2 (zh)
CA (1) CA2203757A1 (zh)
DE (1) DE69524628T2 (zh)
DK (1) DK0788356T3 (zh)
ES (1) ES2170172T3 (zh)
PT (1) PT788356E (zh)
TW (1) TW467743B (zh)
WO (1) WO1996013259A2 (zh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699843B2 (en) * 1995-06-07 2004-03-02 Gilead Sciences, Inc. Method for treatment of tumors using nucleic acid ligands to PDGF
WO1998005999A1 (fr) * 1996-08-06 1998-02-12 Seiko Epson Corporation Affichage a cristaux liquides et materiel electronique l'utilisant
WO2000009113A1 (en) * 1998-08-17 2000-02-24 Trout William E Use of zeranol to modulate reproductive cycles
US20030219427A1 (en) * 1998-08-18 2003-11-27 Allen Hamish J. TPL-2/COT kinase and methods of use
ATE307601T1 (de) * 1998-12-07 2005-11-15 Ecosmart Technologies Inc Brustkrebsbehandlung mittels natürlicher ätherischer öle
EP1140069A1 (en) 1998-12-24 2001-10-10 Novation Pharmaceuticals Inc. COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
HUP0300923A3 (en) * 1999-08-13 2005-12-28 Scripps Research Inst Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras
GB9925958D0 (en) * 1999-11-02 1999-12-29 Bundred Nigel J Therapeutic use
US7087608B2 (en) * 2000-03-03 2006-08-08 Robert Charles Atkins Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤
US6565864B2 (en) 2000-12-28 2003-05-20 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin care product containing retinoids and phytoestrogens in a dual compartment package
DE60218822T2 (de) * 2001-02-09 2007-07-12 Unilever N.V. Nahrungsmittel enthaltend sojaprotein und statin
WO2003041643A2 (en) * 2001-11-09 2003-05-22 Conforma Therapeutics Corporation Hsp90-inhibiting zearalanol compounds and methods of producing and using same
FR2835252B1 (fr) 2002-01-25 2005-08-05 Seppic Sa Utilisation d'un compose inactivant la proteine kinase a dans une composition contenant un milieu cosmetiquement acceptable, pour eclaicir la peau
US7915306B2 (en) * 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
AU2003224672B2 (en) * 2002-03-08 2010-02-04 Eisai R&D Management Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
CA2482940A1 (en) * 2002-04-17 2003-10-23 Taisho Pharmaceuticals Co., Ltd. Hair growth tonic
US8853376B2 (en) 2002-11-21 2014-10-07 Archemix Llc Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
EP1608338A1 (en) * 2003-04-02 2005-12-28 Celator Technologies Inc. Pharmaceutical compositions containing active agents having a lactone group and transition metal ions
EP3168304A1 (en) 2003-08-27 2017-05-17 Ophthotech Corporation Combination therapy for the treatment of ocular neovascular disorders
EP1794137A4 (en) * 2004-09-27 2009-12-02 Kosan Biosciences Inc SPECIFIC KINASE INHIBITORS
US20070149593A1 (en) * 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
US7601852B2 (en) * 2006-05-11 2009-10-13 Kosan Biosciences Incorporated Macrocyclic kinase inhibitors
CN103539769B (zh) * 2006-08-11 2016-03-16 斯特拉斯堡大学 用作激酶抑制剂和hsp90抑制剂的大环化合物
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions
JP5484327B2 (ja) 2007-07-25 2014-05-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 癌の処置において使用するための多キナーゼインヒビター
WO2009058908A2 (en) 2007-10-29 2009-05-07 Eisai R & D Management Co., Ltd. Methods for prognosing the ability of a zearalenone analog compound to treat cancer
CN101889005B (zh) 2007-12-07 2015-06-03 卫材R&D管理株式会社 玉米赤霉烯酮大环内酯类似物合成过程中的中间物
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
WO2010099139A2 (en) 2009-02-25 2010-09-02 Osi Pharmaceuticals, Inc. Combination anti-cancer therapy
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
JP2012519282A (ja) 2009-02-27 2012-08-23 オーエスアイ・ファーマシューティカルズ，エルエルシー 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法
WO2010099363A1 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
CN101928700B (zh) * 2009-07-28 2012-05-02 北京恒宇视野生物科技有限公司 蛋白激酶pftk1单克隆抗体及其制备方法
WO2012021974A1 (en) * 2010-08-20 2012-02-23 The Hospital For Sick Children Compositions and methods for treatment of cystic fibrosis and diseases associated with aberrant protein cellular processing
US9896730B2 (en) 2011-04-25 2018-02-20 OSI Pharmaceuticals, LLC Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
US10434085B2 (en) 2015-06-04 2019-10-08 University Of North Carolina At Greensboro Non-aromatic difluoro analogues of resorcylic acid lactones

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196019A (en) * 1964-04-06 1965-07-20 Purdue Research Foundation Anabolic and estrogenic compound and process of making
JPS6239558A (ja) * 1985-08-13 1987-02-20 Kanegafuchi Chem Ind Co Ltd α−シアノアクリル酸アミド誘導体
JPS6239523A (ja) * 1985-08-14 1987-02-20 Kanegafuchi Chem Ind Co Ltd 酵素阻害剤
JPS6242923A (ja) * 1985-08-19 1987-02-24 Kanegafuchi Chem Ind Co Ltd 酵素阻害剤
JPS6242925A (ja) * 1985-08-20 1987-02-24 Kanegafuchi Chem Ind Co Ltd 酵素阻害剤
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
GB9225396D0 (en) * 1992-12-04 1993-01-27 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0788356A2 (en) 1997-08-13
PT788356E (pt) 2002-06-28
US5795910A (en) 1998-08-18
AU4278996A (en) 1996-05-23
US5728726A (en) 1998-03-17
EP0788356B1 (en) 2001-12-12
TW467743B (en) 2001-12-11
DE69524628T2 (de) 2002-08-08
JPH10508024A (ja) 1998-08-04
ES2170172T3 (es) 2002-08-01
CA2203757A1 (en) 1996-05-09
CN1165481A (zh) 1997-11-19
EP0788356B9 (en) 2002-10-02
US5674892A (en) 1997-10-07
ATE210439T1 (de) 2001-12-15
MX9703113A (es) 1998-06-30
KR970706812A (ko) 1997-12-01
AU706621B2 (en) 1999-06-17
DE69524628D1 (de) 2002-01-24
WO1996013259A2 (en) 1996-05-09
WO1996013259A3 (en) 1996-08-01

Similar Documents

Publication Publication Date Title
DK0788356T3 (da) Fremgangsmåde og præparater til hæmning af proteinkinaser
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO941181D0 (no) Heterocykliske inhibitorer for farnesyl-protein-transferase
YU31392A (sh) Derivati heterocikličnih-cikličnih amina
DK0725790T3 (da) Substituerede tetra- og pentapeptidinhibitorer af proteinfarnesyltransferase
DK0839133T3 (da) Derivater af 4,9-ethano-benzo(f)isoindol, som er anvendelige som farnesyltransferase-inhibitorer
DE69516866T2 (de) Stereochemische wortmanninderivate
NO951647D0 (no) Inhibitorer for farnesylproteintransferase
FI950859A0 (fi) Arylideeni- ja heteroarylideeni-oksindolijohdannaiset tyrosiinikinaasi-inhibiittoreina
NO973607D0 (no) Nye farnesyltransferaseinhibitorer, deres fremstilling og preparater inneholdende inhibitorene
NO961814L (no) Substituerte di- og tripetidinhibitorer for protein:farnesyl-transferase
NO983892L (no) Inhibitorer for farnesyl-proteintransferase
DE69627179T2 (de) Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren
NO991230L (no) Trisykliske forbindelser for inhibering av G-proteinfunksjon og for behandling av proliferative sykdommer
DE69225023T2 (de) Amin-Addukte als Korrosionsinhibitoren
IL127575A0 (en) Prenyl transferase inhibitors
ATE262584T1 (de) Verwendung eines inhibitors von tau/neurofilament-proteinkinase pk40
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
NO970350L (no) Forbindelser anvendelige som anti-formeringsmidler og GARFT-inhibitorer
AR003529A1 (es) Derivados de alfa-fenilpiperidin-1-propanol, procedimiento para su preparacion y su aplicacion terapeutica.
ATE227281T1 (de) Verbindungen als farnesyl-protein transferase inhibitoren